rs28941783
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000187.4(HGD):c.481G>A(p.Gly161Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000917 in 1,613,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G161E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000187.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HGD | NM_000187.4 | c.481G>A | p.Gly161Arg | missense_variant | 8/14 | ENST00000283871.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HGD | ENST00000283871.10 | c.481G>A | p.Gly161Arg | missense_variant | 8/14 | 1 | NM_000187.4 | P1 | |
HGD | ENST00000476082.2 | c.358G>A | p.Gly120Arg | missense_variant | 7/7 | 5 | |||
HGD | ENST00000475447.2 | c.13G>A | p.Gly5Arg | missense_variant | 1/5 | 3 | |||
HGD | ENST00000492108.5 | c.112G>A | p.Gly38Arg | missense_variant, NMD_transcript_variant | 3/6 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.000158 AC: 24AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000876 AC: 22AN: 251104Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135696
GnomAD4 exome AF: 0.0000848 AC: 124AN: 1461700Hom.: 0 Cov.: 31 AF XY: 0.000106 AC XY: 77AN XY: 727182
GnomAD4 genome ? AF: 0.000158 AC: 24AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74340
ClinVar
Submissions by phenotype
Alkaptonuria Pathogenic:8Other:1
Pathogenic, no assertion criteria provided | research | Department Of Human Genetics, Institute Of Clinical And Translational Research, Biomedical Research Center, Slovak Academy Of Sciences | - | The variant was originally described in AKU patient in PMID:9154114. It has been submitted to the HGD gene mutation database (http://hgddatabase.cvtisr.sk/, DB-ID: AKU_00050). - |
not provided, no classification provided | literature only | GeneReviews | - | 1 of 4 founder variants in the Slovak population - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 20, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Medical Genetics, National & Kapodistrian University of Athens | Oct 01, 2021 | PS3, PM2, PP2, PP3, PP4, PP5 - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 21, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 161 of the HGD protein (p.Gly161Arg). This variant is present in population databases (rs28941783, gnomAD 0.03%). This missense change has been observed in individuals with alkaptonuria (PMID: 9154114, 12051967, 19862842, 20462779). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 3168). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt HGD protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects HGD function (PMID: 10482952). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 04, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2000 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Mar 09, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 05, 2019 | Across a selection of the available literature, the HGD c.481G>A (p.Gly161Arg) missense variant has been identified in 55 individuals with alkaptonuria, including in a homozygous state in 27 individuals and in a compound heterozygous state in 38 individuals, and is also found in a heterozygous state in 25 unaffected individuals (Gehrig et al. 1997; Vilboux et al. 2009; Zatkova et al. 2012; Usher et al. 2015; Nemethova et al. 2015; Cieszynski et al. 2016). The p.Gly161Arg variant was also shown to segregate with disease in a three-generation family with one affected homozygote (Gehrig et al. 1997). The variant was absent from 384 control chromosomes but is reported at a frequency of 0.000269 in the European (non-Finnish) population of the Genome Aggregation Database. The Gly161 residue is conserved. Variant enzyme activity assays performed in E. coli demonstarted that the p.Gly161Arg variant resulted in one percent activity in comparison to wild type (Rodriguez et al. 2000). Based on the collective evidence, the p.Gly161Arg variant is classified as pathogenic for alkaptonuria. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at